Clinical Study of Novel Skin Biomarker Test for Alzheimer’s Disease Gains Vigorous Physician Support in Long-Sought Early Detection Breakthrough
Author of publication
Frederick Huie, MD, Medical DIrector, CVS/Aetna and Advisory Council Member, SYNAPS Dx Scott C. Howell, D.O.
DISCERN™ PKCƐ Assay for Alzheimer’s Disease Measuring synaptic dysfunction to inform a highly accurate diagnose Alzheimer’s Dementia in early dementia.
Morphometric imaging biomarker identifies Alzheimer’s disease even among mixed dementia patients
SYNAPS Dx Honors Caregivers, Patients and Families During
National Alzheimer’s Disease Awareness Month
National Family Caregivers Month
Navigating Dementia Care: Unveiling the GUIDE Model, the Importance of Annual Wellness Visits and Advancements in Alzheimer’s Diagnosis
SYNAPS Dx Honors Residents, Families, Staff and Volunteers in Assisted Living Communities
Alzheimer’s Disease: Know the Factors, Recognize Opportunities to Reduce Risk
SYNAPS Dx President and CEO, Frank Amato, Featured on Business Ninjas Podcast
Input your search keywords and press Enter.